LKFT:AMS
Lakefront Biotherapeutics NV
€25.66
arrow_downward
-0.23%(-0.060) 1D
Oct 2, 5:35:12 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LKFT...
Open
€25.40
High
€26.06
Low
€25.28
Mkt. cap
1.67B
Avg. vol.
100.40K
Volume
82.82K
52-wk high
€28.42
52-wk low
€22.32
No. of employees
196
Open
€25.40
High
€26.06
Low
€25.28
Mkt. cap
1.67B
Avg. vol.
100.40K
Volume
82.82K
52-wk high
€28.42
52-wk low
€22.32
No. of employees
196
News stories
From web sources and news partners
KuCoin
·
28 minutes ago
Anthropic's Private Valuation Surges 22x, Outpacing Nvidia and Nasdaq 100
MarketBeat
·
43 minutes ago
Xometry (NASDAQ:XMTR) Director Sells $591,093.72 in Stock
Simply Wall Street
·
1 hour ago
Ionis Pharmaceuticals Fell 45% With The Case Still Split
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com